Quick Answer
C4 Therapeutics, Inc. reported Net Income of -$104.99 million for fiscal year 2025.
C4 Therapeutics, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$104.99M | +0.3% |
| 2024 | -$105.32M | +20.5% |
| 2023 | -$132.49M | -3.4% |
| 2022 | -$128.18M | -52.8% |
| 2021 | -$83.89M | -26.5% |
| 2020 | -$66.33M | -94.5% |
| 2019 | -$34.10M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$32.17M | -30.4% | -23.6% |
| June 30, 2025 | -$26.02M | -46.9% | +1.1% |
| March 31, 2025 | -$26.32M | +7.2% | -6.7% |
| September 30, 2024 | -$24.67M | +8.8% | -39.2% |
| June 30, 2024 | -$17.72M | +50.7% | +37.5% |
| March 31, 2024 | -$28.36M | +18.5% | -4.9% |
| September 30, 2023 | -$27.04M | +15.4% | +24.7% |
| June 30, 2023 | -$35.92M | -31.0% | -3.3% |
- C4 Therapeutics, Inc. showed an increase of +0.3% in Net Income compared to the prior fiscal year.
- Over the 2019–2025 period, C4 Therapeutics, Inc.’s net income has declined by 207.9% (from -$34.10 million to -$104.99 million).
- The most recent figure is from C4 Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: